ArticleTranslational lung cancer research2019
Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty and life expectancy.
Article in Translational lung cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- The use of a novel urine biosensor platform for lung cancer detection during lung cancer screening.JTCVS open · 2026Article
- Construction and validation of frailty risk prediction model in elderly patients with colorectal cancer.BMC geriatrics · 2025Article
- Development and validation of frailty risk prediction model for elderly patients with coronary heart disease.BMC geriatrics · 2024Article
- Tackling Guideline Non-concordance: Primary Care Barriers to Incorporating Life Expectancy into Lung Cancer Screening Decision-Making-A Qualitative Study.Journal of general internal medicine · 2024Article
- Current Evidence for a Lung Cancer Screening Program.Portuguese journal of public health · 2024Review
- The Benefits and Harms of Lung Cancer Screening in Individuals With Comorbidities.JTO clinical and research reports · 2024Article
- The Impact of Race-Ethnicity and Diagnosis of Alzheimer's Disease and Related Dementias on Mammography Use.Cancers · 2022Article
- Prevalence And Impact of Medical Comorbidities in A Real-World Lung Cancer Screening Population.Clinical lung cancer · 2022Article
- Comparing the downstream costs and healthcare utilization associated with the use of low-dose computed tomography (LDCT) in lung cancer screening in patients with and without alzheimer's disease and related dementias (ADRD).Current medical research and opinion · 2021Article
- Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.British journal of cancer · 2021Article
- Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.Journal of cachexia, sarcopenia and muscle · 2021Article
- Evaluation of preoperative cardiopulmonary reserve and surgical risk of patients undergoing lung cancer resection.Therapeutic advances in respiratory diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.